A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: Dosimetry, biodistribution, pharmacokinetics, and safety

Joseph J. Grudzinski, Benjamin Titz, Kevin Kozak, William Clarke, Ernest Allen, Lisaann Trembath, Michael Stabin, John Marshall, Steve Y. Cho, Terence Z. Wong, Joanne Mortimer, Jamey P. Weichert

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: Dosimetry, biodistribution, pharmacokinetics, and safety'. Together they form a unique fingerprint.

Chemical Compounds

Agriculture & Biology

Medicine & Life Sciences